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Hsp60 is, typically, a mitochondrial protein, but it also occurs in the cytosol, vesi-
cles, and plasma membrane, and in the intercellular space and biological fluids, e.g., 
blood. Changes in the levels and distribution of Hsp60 are linked to several patholo-
gies, including cancer and chronic inflammatory and autoimmune disorders. What is 
the histopathological pattern of Hsp60 in the thyroid of Hashimoto’s patients? Are 
there indications of a pathogenic role of Hsp60 that may make Hashimoto’s thy-
roiditis a chaperonopathy? Experiments reported here provide information regarding 
those questions. We found by various immunomorphological techniques increased 
levels of Hsp60 in the thyroid from HT patients, localized to thyrocytes of small and 
degenerated follicles and to oncocytes (Hurtle cells). Immunofluorescence showed the 
chaperonin both inside the cells and also in the plasma membrane, especially in onco-
cytes. We also found that Hsp60 levels in the blood of HT patients were increased 
compared to controls and correlated with those of autoantibodies against two distinc-
tive thyroidal proteins, thyroglobulin (TG) and thyroid peroxidase (TPO) (r=0.379, 
p=0.0103; r=0.484, p=0.0008; respectively). Molecular analysis of these two proteins 
in comparison with Hsp60 demonstrated various regions of high structural similar-
ity shared by them, which could very well be immunologically crossreactive epitopes. 
Thus, it is likely that the three proteins potentiate each other as immunogens to elicit 
autoantibodies and, as antigens, to cause antigen-antibody reactions at those sites in 
which Hsp60 is exposed, for example the surface of oncocytes. This would lead to 
inflammation and oncocyte lysis with destruction of thyroidal tissue. The cytometric 
bead assay revealed that recombinant Hsp60 did not induce increment of cytokine 
production by peripheral blood mononuclear cells from HT patients. Consequently, 
we propose that Hsp60 is implicated in the pathogenesis of Hashimoto’s thyroiditis 
as autoantigen, via a participation of autoantibodies that also recognize TG and TPO, 
whereas participation of inflammatory cytokines induced by the chaperonin is unlike-
ly. Supported by IEMEST (FC and AJLM).
